Posted by admin on Aug 9th, 2022

Envestnet Asset Management Inc. cut its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 0.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 163,861 shares of the medical instruments supplier’s stock after selling 1,120 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.08% of DENTSPLY SIRONA worth $8,065,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. raised its holdings in shares of DENTSPLY SIRONA by 4.2% in the 4th quarter. BlackRock Inc. now owns 17,700,553 shares of the medical instruments supplier’s stock valued at $987,514,000 after purchasing an additional 709,095 shares during the period. First Eagle Investment Management LLC raised its holdings in shares of DENTSPLY SIRONA by 16.5% in the 4th quarter. First Eagle Investment Management LLC now owns 7,184,012 shares of the medical instruments supplier’s stock valued at $400,796,000 after purchasing an additional 1,018,179 shares during the period. Champlain Investment Partners LLC raised its holdings in shares of DENTSPLY SIRONA by 15.6% in the 4th quarter. Champlain Investment Partners LLC now owns 5,436,245 shares of the medical instruments supplier’s stock valued at $303,288,000 after purchasing an additional 733,144 shares during the period. Invesco Ltd. raised its holdings in shares of DENTSPLY SIRONA by 12.2% in the 4th quarter. Invesco Ltd. now owns 4,452,530 shares of the medical instruments supplier’s stock valued at $248,406,000 after purchasing an additional 482,532 shares during the period. Finally, Geode Capital Management LLC grew its stake in DENTSPLY SIRONA by 7.2% in the 4th quarter. Geode Capital Management LLC now owns 4,352,885 shares of the medical instruments supplier’s stock valued at $242,283,000 after buying an additional 291,705 shares during the last quarter. 94.79% of the stock is owned by institutional investors.

A number of research analysts recently commented on the stock. UBS Group upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and decreased their price target for the company from $58.00 to $47.00 in a research note on Wednesday, June 1st. Piper Sandler decreased their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 in a research note on Monday, July 11th. Robert W. Baird lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $67.00 to $48.00 in a research note on Tuesday, April 19th. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $53.00 to $51.00 in a research report on Wednesday, May 11th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $48.11.

NASDAQ XRAY opened at $36.99 on Tuesday. The company has a current ratio of 1.45, a quick ratio of 1.03 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $7.97 billion, a price-to-earnings ratio of 21.89, a P/E/G ratio of 2.97 and a beta of 0.91. The firm’s 50 day simple moving average is $36.51 and its 200 day simple moving average is $43.72. DENTSPLY SIRONA Inc. has a 1 year low of $33.78 and a 1 year high of $63.10.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its quarterly earnings data on Tuesday, May 10th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.50 by $0.02. The business had revenue of $9.67 billion during the quarter, compared to the consensus estimate of $982.05 million. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The firm’s revenue was up 841.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.72 EPS. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 2.41 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 8th. Investors of record on Friday, June 24th were paid a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 1.35%. The ex-dividend date was Thursday, June 23rd. DENTSPLY SIRONA’s payout ratio is 29.59%.

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Trimble (NASDAQ:TRMB) Given New $82.00 Price Target at Piper Sandler

Advisor Group Holdings Inc. Buys 59,227 Shares of Vale S.A. (NYSE:VALE)